Literature DB >> 19090545

Prevention of homozygous beta thalassemia by premarital screening and prenatal diagnosis in India.

Parag M Tamhankar1, Sarita Agarwal, Vandana Arya, Ravindra Kumar, U R Gupta, S S Agarwal.   

Abstract

AIM: To determine the feasibility and acceptability of premarital screening for beta thalassemia/related hemoglobinopathies followed by prenatal diagnosis in India.
MATERIALS AND METHODS: Premarital testing for thalassemia carrier state was carried out in (1) extended family members (EFM) of diagnosed cases of thalassemia/hemoglobinopathies, (2) unmarried adult cases of anemia attending the hospitals' outpatient department (OPD) and (3) adult college students (CG). Hemoglobin, red cell indices were measured by a cell counter and hemoglobin fractionation was carried out by high performance liquid chromatography (HPLC). In cases with HbA2>3.5%, or with variant hemoglobin, mutation screen was done by amplification refractory mutation system polymerase chain reaction (ARMS-PCR). In high-risk prospective couples, premarital genetic counseling was done and prenatal diagnosis possibilities were explained.
RESULTS: The yield of carriers from EFM, OPD and CG groups was 78.17% (308/394), 19.51% (263/1348) and 4.04% (38/939), respectively. The number of prospective high-risk couples detected were 154, 48 and 2 from EFM, OPD and CG, respectively. As much as 99% of prospective carrier couples married even after knowing their high-risk status and opted for prenatal diagnosis. The program averted the birth of 33 thalassemic children; 28 in EFM group (by screening of 394 individuals), 4 in the OPD group (by screening 1348 anemic patients), and 1 in CG group (by screening of 939 students).
CONCLUSION: Premarital screening in extended family members, followed by prenatal diagnosis is acceptable and the most effective strategy for control of thalassemia in developing countries like India. Copyright (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2009        PMID: 19090545     DOI: 10.1002/pd.2176

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  15 in total

1.  Profiling β-thalassaemia mutations in India at state and regional levels: implications for genetic education, screening and counselling programmes.

Authors:  S Sinha; M L Black; S Agarwal; R Colah; R Das; K Ryan; M Bellgard; A H Bittles
Journal:  Hugo J       Date:  2010-02-10

2.  Analysis of β/α globin ratio by using relative qRT-PCR for diagnosis of beta-thalassemia carriers.

Authors:  Reza Ranjbaran; Mohammad Ali Okhovat; Arash Mobarhanfard; Farzaneh Aboualizadeh; Mozhdeh Abbasi; Leili Moezzi; Habib Allah Golafshan; Abbas Behzad-Behbahani; Mandana Bagheri; Sedigheh Sharifzadeh
Journal:  J Clin Lab Anal       Date:  2013-07       Impact factor: 2.352

3.  Clinicoinvestigational and demographic profile of children with thalassemia major.

Authors:  Amita Trehan; Nivedita Sharma; Reena Das; Deepak Bansal; R K Marwaha
Journal:  Indian J Hematol Blood Transfus       Date:  2014-04-20       Impact factor: 0.900

4.  Frequency of β-thalassemia trait and other hemoglobinopathies in northern and western India.

Authors:  Nishi Madan; Satendra Sharma; S K Sood; Roshan Colah; Late H M Bhatia
Journal:  Indian J Hum Genet       Date:  2010-01

5.  Socio-demographic Profile and Economic Burden of Treatment of Transfusion Dependent Thalassemia.

Authors:  Amita Moirangthem; Shubha R Phadke
Journal:  Indian J Pediatr       Date:  2017-11-09       Impact factor: 1.967

6.  Haemoglobinopathies in eastern Indian states: a demographic evaluation.

Authors:  Rachana Nagar; Sujata Sinha; Rajiva Raman
Journal:  J Community Genet       Date:  2014-07-25

7.  Can RBC Indices be Used as Screening Test for Beta-Thalassemia in Indian Antenatal Women?

Authors:  Mayura Baliyan; Manisha Kumar; Anita Nangia; Nupur Parakh
Journal:  J Obstet Gynaecol India       Date:  2019-03-28

8.  Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and β-thalassemia in Saudi Arabia.

Authors:  Ziad Ahmed Memish; Mohammad Y Saeedi
Journal:  Ann Saudi Med       Date:  2011 May-Jun       Impact factor: 1.526

Review 9.  Past, present & future scenario of thalassaemic care & control in India.

Authors:  Ishwar C Verma; Renu Saxena; Sudha Kohli
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

10.  Factors influencing the decision to participate in medical premarital examinations in Hubei Province, Mid-China.

Authors:  Peigang Wang; Xiao Wang; Min Fang; Tyler J Vander Weele
Journal:  BMC Public Health       Date:  2013-03-11       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.